Application of a Novel Murine Model of Mucopolysaccharidosis Type II for Developing Human Hematopoietic Stem Cell Gene Therapy

被引：0
|
作者：
Shimada, Yohta [1 ]
Ishii, Natsumi [1 ]
Higuchi, Takashi [1 ]
Goto, Motohito [2 ]
Ohashi, Toya [3 ]
Kobayashi, Hiroshi [1 ]
机构：
[1] Jikei Univ, Sch Med, Res Ctr Med Sci, Div Gene Therapy, Tokyo, Japan
[2] Cent Inst Expt Anim CIEA, Anim Resource Technol Ctr, Kawasaki, Kanagawa, Japan
[3] Jikei Univ, Sch Nursing, Dept Human Hlth Sci & Therapeut, Tokyo, Japan
来源：
MOLECULAR THERAPY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
234
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [31] Correction of murine hemophilia a by hematopoietic stem cell gene therapy.
    Hawley, RG
    Moayeri, M
    Hawley, TS
    BLOOD, 2005, 106 (11) : 376A - 376A
  • [32] Efficacy of hematopoietic stem cell transplantation versus enzyme replacement therapy on brain function in patients with mucopolysaccharidosis type II
    Tanaka, Akemi
    Hamazaki, Takashi
    Okuyama, Torayuki
    Suzuki, Yasuyuki
    Sakai, Norio
    Kosuga, Motomichi
    Shinpo, Michiko
    Yabe, Hiromasa
    Ishige, Mika
    Mugishima, Hideo
    Tabuchi, Ken
    Kato, Shunichi
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (02) : S103 - S103
  • [33] RETROVIRUS VECTOR STUDIES TOWARD HEMATOPOIETIC STEM-CELL GENE-THERAPY FOR MUCOPOLYSACCHARIDOSIS TYPE-I
    PAN, D
    ARONOVICH, EL
    MCIVOR, RS
    WHITLEY, CB
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 1435 - 1435
  • [34] Hematopoietic stem cell gene therapy for chronic granulomatous disease using a selective amplifier gene in a murine model
    Hara, T
    Kume, A
    Hanazono, Y
    Okada, T
    Mizukami, H
    Ueda, Y
    Hasegawa, M
    Ozawa, K
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (07) : 94 - 94
  • [35] Development of Lentiviral Mediated Stem Cell Gene Therapy for Mucopolysaccharidosis Type IIIA
    Ellison, Stuart
    Sergijenko, Ana
    Langford-Smith, Alex
    Langford-Smith, Kia
    Wraith, Ed
    Wynn, Rob
    Wilkinson, Fiona
    Bigger, Brian
    MOLECULAR THERAPY, 2014, 22 : S8 - S8
  • [36] Haematopoietic stem cell gene therapy corrects the brain in mucopolysaccharidosis type IIIB
    Holley, Rebecca
    Ellison, Stuart
    Fil, Daniel
    O'Leary, Claire
    McDermott, John
    Senthivel, Misha
    Langford-smith, Alex
    Wilkinson, Fiona
    Dickson, P.
    Bigger, Brian
    HUMAN GENE THERAPY, 2017, 28 (08) : A12 - A12
  • [37] Non-Myeloablative Conditioning Regimen Using an Anti-Ckit Antibody for Hematopoietic Stemcell Targeted Gene Therapy for a Murine Model of Mucopolysaccharidosis Type II
    Miwa, Saori
    Shimada, Yohta
    Higuchi, Takashi
    Kobayashi, Hiroshi
    Ohashi, Toya
    MOLECULAR THERAPY, 2018, 26 (05) : 254 - 255
  • [38] Activity of daily life in patients with mucopolysaccharidosis type II after hematopoietic stem cell transplantation
    Tomatsu, Shunji
    Taylor, Madeleine
    Suzuki, Yasuyuki
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S154 - S154
  • [39] Neurodevelopmental Outcomes of Hematopoietic Stem Cell Transplantation for Mucopolysaccharidosis Type II: A Prospective, Longitudinal Study
    Escolar, Maria
    Bascou, Nicholas
    Kiely, Bridget
    Safonova, Aleksandra
    Beltran, Maria
    Poe, Michele
    Szabolcs, Paul
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 437 - 437
  • [40] Assessment of Activity of Daily Life in Mucopolysaccharidosis Type II Patients with Hematopoietic Stem Cell Transplantation
    Suzuki, Yasuyuki
    Taylor, Madeleine
    Orii, Kenji
    Fukao, Toshiyuki
    Orii, Tadao
    Tomatsu, Shunji
    DIAGNOSTICS, 2020, 10 (01)
12345